Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...
Oct. 21, 2026 — The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for non-invasive ...
Oct. 22, 2026 — Henry Ford Health has performed the first procedures globally in a clinical trial evaluating pulmonary ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Oct. 20, 2026 — Penumbra, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted clearance ...
With a sirolimus-based drug-coated balloon (DCBs) entering the U.S. market, interventional cardiologists treating in ...
Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter ...
Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...
Oct. 14, 2026 — W. L. Gore & Associates' medical business has announced U.S. Food and Drug Administration approval of an ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Medical device portfolios now move on two very different clocks. New technologies can gain clinical adoption within ...
Oct. 12, 2026 — Endovascular Engineering (E2) has announced that the U.S. Food and Drug Administration (FDA) has granted ...
Oct. 12, 2026 — The American Heart Association has expanded its education portfolio to help clinicians put the new ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Oct. 12, 2026 — Siemens Healthineers announced it ultrasound business plans to concentrate its efforts on cardiovascular ...
Oct. 6, 2026 — Penumbra, Inc. has announced results from a subset analysis of the landmark STORM-PE randomized ...
Oct. 8, 2026 – At the Heart Failure Society of America (HFSA) Annual Scientific Meeting in Phoenix, Arizona, Bayer ...
October 23, 2026
